Clinical Roundup American Lung Association launches campaign to address barriers to lung cancer screening and care October 03, 2025Vol.51 No.36
Clinical Roundup EU launches DISARM project to tackle ovarian cancer risk and early detection October 03, 2025Vol.51 No.36
Clinical Roundup Novel immune system boost helps fight cancer cells, JHU study finds October 03, 2025Vol.51 No.36
Clinical Roundup Genetic “Trojan horse” selectively kills cancer cells linked to Kaposi’s sarcoma, UC Davis study shows October 03, 2025Vol.51 No.36
Clinical Roundup Wistar scientists identify novel therapeutic target for ovarian cancer October 03, 2025Vol.51 No.36
Drugs & Targets FDA approves Zepzelca + Tecentriq combination as first-line maintenance therapy for ES-SCLC October 03, 2025Vol.51 No.36
Drugs & Targets FDA approves Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer October 03, 2025Vol.51 No.36
Drugs & Targets FDA grants Fast Track Designation to UB-VV111 in vivo CAR T-cell therapy October 03, 2025Vol.51 No.36
